Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Emergency Departments Need Plan to Deal with Drug Shortages

By James J. Augustine, MD, FACEP | on August 15, 2017 | 0 Comment
Features
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
Emergency Departments Need Plan to Deal with Drug Shortages

In recent years, there have been countless unprecedented, unexpected, and unplanned short-term medication shortages and ever more promises that long-term remedies were being implemented. However, the manufacturers and the federal agencies that oversee drug supply and manufacturing practices—the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA)—have continued to be at odds over safe manufacturing and quality processes, and once again, there are life-threatening problems with medication supplies for emergency providers.

You Might Also Like
  • FDA Launches Mobile App to Alert Public About Drug Shortages
  • Emergency Physicians Encouraged to Draw Attention to Pharmaceutical Drug Shortages
  • ACEP Submits Comments on Drug Shortages, Managed Care Regulations
Explore This Issue
ACEP Now: Vol 36 – No 08 – August 2017

The shortage crisis affects drugs across all classes of emergency medications. As of June 26, 2017, there are 69 preparations of 28 emergency care medications that are short, including most forms of adenosine, atropine, bicarbonate, calcium, dextrose, dopamine, epinephrine, fentanyl, furosemide, labetalol, magnesium, lorazepam, and the paralytic agents. There are an additional 50 large-volume intravenous fluid preparations that are unavailable. The most publicized issue has been related to the hospital shortage of bicarbonate, which affects a wide range of patients.

In response to significant pressure from health care providers, including the emergency community, the FDA has taken two actions. It has approved the sourcing of sodium bicarbonate from an Australian medication manufacturer, a step that mirrors a prior action allowing the importation of normal saline solution from a Norwegian manufacturer in 2014. The FDA has also allowed the extension of expiration dates on some lots of three emergency medications: atropine, dextrose, and epinephrine.

It is important that emergency physicians understand the details of this extension program and can share this information with hospital pharmacists, C-suite leaders, and any regulatory agencies. The details are available on the FDA website.

This extension program will assist in the crisis management of the shortage of these three emergency medications. The program, which could potentially be extended to other medications, allows emergency providers to use medications currently in stock for patient care. It will also facilitate a short-term cost savings because the replacement costs of these medications are going to be significantly higher during the shortage. For example, a recent price for a single 1 mg vial of epinephrine 1:1000 was more than $17. In recent years, it cost less than $2.

Action Plan

Emergency physicians will need to work with hospital pharmacists and logistics personnel for EMS agencies to ensure the ongoing availability of emergency medications and intravenous fluids. The FDA notification is a good reason to convene a meeting of emergency department leaders and hospital pharmacists to discuss ongoing management strategies. All emergency physicians and nurses are going to need education on any hospital program that involves using medicines beyond printed expiration dates. The printed FDA notification should be available for those providers as well as any regulatory persons who inspect the emergency department and question this practice.

Pages: 1 2 | Single Page

Topics: Cost of Health CareDrug Enforcement AdministrationDrug ShortageEmergency DepartmentEmergency MedicineEmergency PhysiciansEMSFDALeadershipMedicationPractice ManagementPublic Health

Related

  • Dr. Joe Sachs and “The Pitt” Are Redefining Public Health Education Through Storytelling

    June 11, 2025 - 0 Comment
  • ACEP4U: Reinventing Research Education

    June 11, 2025 - 0 Comment
  • Prehospital Buprenorphine Is a Powerful Tool in the Opioid-Crisis Fight

    June 4, 2025 - 0 Comment

Current Issue

ACEP Now May 03

Download PDF

Read More

About the Author

James J. Augustine, MD, FACEP

James J. Augustine, MD, FACEP, is national director of prehospital strategy for US Acute Care Solutions in Canton, Ohio; clinical professor of emergency medicine at Wright State University in Dayton, Ohio; and vice president of the Emergency Department Benchmarking Alliance.

View this author's posts »

No Responses to “Emergency Departments Need Plan to Deal with Drug Shortages”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603